Selective attention in never-medicated patients with schizophrenia;Attention selective et schizophrenie avant l'administration de neuroleptiques

Encephale

Volumn 25, Issue 6, 1999, Pages 576-583

  Lussier, I ^b   Stip, E ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b NONE

Author keywords

Attention; Cognition; Drug naive patients; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; REACTION TIME; SCHIZOPHRENIA; SELECTIVE ATTENTION; THEORY; ADOLESCENT; ATTENTION; BRIEF PSYCHIATRIC RATING SCALE; HOSPITALIZATION; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; PSYCHOLOGY;

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 0033395044     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual for Mental Disorders (3nd ed revised). Washington, DC : APA, 1987.
2. BENCH CJ, FRITH CD, GRASBY PM et al. Investigations of the functional anatomy of attention using the Stroop test. Neuropsychologia 1993 ; 31 : 907-22.
3. BIANCHI A, ZOLO P, SALMASO D. Effects of frontal lesions on a selective attention task. Italian J Neurological Sci 1993 ; 14 : 355-9.
4. BOUCART M, MOBAREK N, CUERVO C et al. What is the nature of increased Stoop interference in schizophrenia ? Acta Psychol 1999 ; 101 (1) : 3-25.
5. BUB D, GUM T. Psychlab software. Montréal : McGill University, 1987.
6. CARPENTER WT, HEINRICHS DW, WAGMAN AMI. Deficit and nondeficit forms of schizophrenia : the concept. Am J Psychiatry 1988 ; 145 : 578-83.
7. CHOUINARD G, ROSS-CHOUINARD A, ANNABLE L et al. Extra-pyramidal Symptom Rating Scale. Canadian J Neurological Sci 1980 ; 7 : 233.
8. CLARK CR, GEFFEN GM, GEFFEN LB. Catecholamines and attention I : Animal and clinical studies. Neurosc Biobehav Rev 1987a ; 11 : 341-52.
9. CLARK CR, GEFFEN GM, GEFFEN LB. Catecholamines and attention II : Pharmacological studies in normal humans. Neurosc Biobehav Rev 1987b ; 11 : 353-64.
10. CORBETTA M, SHULMAN GL, MIEZIN FM et al. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction. Science 1995 ; 270 (5237) : 802-5.
11. DELISI LE, TEW W, XIE S. et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients : preliminary findings. Biological Psychiatry 1995 ; 38 : 349-60.
12. EARLE-BOYER EA, SERPER MR, DAVIDSON M. et al. Continuous performance tests in schizophrenic patients : stimulus and medication effects on performance. Psychiatr Res 1991 ; 37 : 47-56.
13. EVERETT J, LAPLANTE L. Déficit d'attention sélective et schizophrénie. Approche multidisciplinaire et test de Stroop. Encephale 1991 ; XVII : 171-8.
14. FOLSTEIN MF, FOLSTEIN SE, McHUGH PR. Mini-Mental State. J Psychiatr Res 1975 ; 12 : 189-98.
15. FRIEDMAN-HILL SR, ROBERSTSON LC, TREAISMAN A. Parietal contributions to visual feature binding : evidence from a patient with bilateral lesions. Science 1995 ; 269 (5225) : 853-5.
16. GOLD MJ, HARVEY PD. Cognitive deficits in schizophrenia. Psychiatr Clin N Am 1993 ; 16 : 295-310.
17. GOLDBERG TE, GOLD JM. Neurocognitive functioning in patients with schizophrenia. In : Bloom FE, Kupfer DJ, eds. Psychopharmacology, The Fourth Generation in Progress. New York : Raven Press, Ltd, 1995 : 1245-57.
18. GOLDBERG TE, HYDE TM, KLEINMAN JE et al. Course of schizophrenia : neuropsychological evidence for a static encephalopathy. Schizophrenia Bull 1993 ; 19 : 797-804.
19. GREEN MF. What are the functional consequences of neurocognitive deficits in schizophrenia ? Am J Psychiatry 1996 ; 153 : 321-30.
20. HAIN C, MAIER W, KLINGER T et al. Positive/negative symptomatology and experimental measures of attention in schizophrenic patients. Psychopathology 1993 ; 26 : 62-8.
21. HOFF AL, RIORDAN H, O'DONNELL DW et al. Neuropsychological functioning of first-episode schizophreniform patients. Am J Psychiatry 1992 ; 149 : 898-903.
22. JONES SH, HEMSLEY DR, GRAY JA. A contextual effect of choice reaction time and accuracy in acute and chronic schizophrenics. Br J Psychiatry 1991 ; 159 : 415-21.
23. KAY SR, FISZBEIN A, OPLER LA. The positive and negative syndrome scale. Schizophrenia Bull 1987 ; 13 : 261-76.
24. KRAEPELIN E. Dementia Praecox and Paraphrenia (translated by RM Barclay). Edinburg : Churchill Levingstone, 1919.
25. LIEB K, MERKLIN G, RIETH C et al. Preattentive information processing in schizophrenia. Schizophrenia Res 1994 ; 14 : 47-56.
26. LIOTTI M, DAZZI S, UMILTA C. Deficits in the automatic orienting of attention in schizophrenic patients. J Psychiatr Res 1993 ; 27 : 119-30.
27. LUSSIER I, STIP E. The effects of Risperidone on cognitive and psychopathological manisfestations of schizophrenia. CNS Spectrum 1998; 3 (10) : 55-69.
28. LUPIEN S, LECOURS AR, LUSSIER I et al. Basal corticol levels and cognitive deficits in human aging. J Neuroscience 1994 ; 14 : 2893-903.
29. NOPOULOS P, FLASHMAN L, FLAUM M et al. Stability of cognitive functioning early in the course of schizophrenia. Schizophrenia Res 1994 ; 14 : 29-37.
30. OVERALL JE, GORHAM DR. Brief Psychiatric Rating Scale. Psychol Rep 1962 ; 10 : 799-812.
31. POSNER MI. Orienting of attention. Quarterly J Experimental Psychology 1980 ; 32 : 3-25.
32. POSNER MI, PETERSEN SE. The attention system of the human brain. Ann Rev Neuroscience 1990 ; 13 : 25-42.
33. POSNER MI. Attention : the mechanisms of consciousness. Proceedings of the National Academy of Sciences of the United States of America 1994 ; 91 : 7398-40.
34. SALO R, ROBERTSON LC, NORDAHL TE. Normal sustained effects of selective attention are absent in schizophrenic patients withdrawn from medication. Psychiatry Res 1996 ; 62 : 121-30.
35. SAX KW, STRAKOWSKI SM, KECK PE et al. Symptoms correlates of attentional improvement following hospitalization for first episode of affective psychosis. Biol Psychiatry 1998 ; 44 (8) : 784-6.
36. SAYKIN AJ, SHTASEL DL, GUR RE et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994 ; 51 : 124-31.
37. SERPER MR, BERGMAN RL, HARVEY PD. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res 1990 ; 32 : 281-8.
38. SERPER MR, DAVIDSON M, HARVEY PD. Attentional predictors of clinical change during neuroleptic treatment in schizophrenia. Schizophrenia Res 1994 ; 13 : 65-71.
39. SPOHN HE, STRAUSS ME. Relation of neuroleptic and antipsychotic medication to cognitive function in schizophrenia. J Abnormal Psychology 1989 ; 98 : 367-80.
40. STIP E, LUSSIER I, BABAIM et al. «Seroquel» and cognitive improvement in patient with schizophrenia. Biological Psychiatry 1996 ; 40 : 434-5.
41. STIP E, LUSSIER I. Neuroleptiques atypiques et attention sélective. Encephale (sous presse).
42. STROOP JR. Studies of interference in serial verbal reactions. J Experimental Psychology 1935 ; 8 : 643-62.
43. SWEENEY JA, GRETCHEN LH, KEILP JG et al. Evaluation of the stability of neuropsychological functioning after acute episodes of schizophrenia : One year followup study. Psychiatry Res 1992 ; 38 : 63-76.
44. TREISMAN A, GELADE G. A feature integration theory of attention. Cognitive Psychology 1980 ; 12 : 97-136.
45. TREISMAN A, SATO S. Conjunction search revisited. J Experimental Psychology, Human Perception and Performance 1990 ; 16 : 459-78.
46. TREISMAN A. Search, similarity, and integration of features between and within dimensions. J Experimental Psychology : Perception and Performance 1991 ; 17 : 652-76.
47. WIGAL SB, SWANSON JM, POTKIN SG. Lateralized attentional deficits in drug-free and medicated schizophrenic patients. Neuropsychologia 1997 ; 35 (12) : 1519-25.